IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

To describe molecular monitoring of minimal residual disease in patients with myeloma who have achieved complete remission (CR) after autologous or allogeneic transplantation of hematopoietic cells.

Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells / P. Corradini, C. Voena, C. Tarella, M. Astolfi, M. Ladetto, A. Palumbo, M. T. Van Lint, A. Bacigalupo, A. Santoro, M. Musso, I. Majolino, M. Boccadoro, A. Pileri. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 17:1(1999 Jan), pp. 208-15-215.

Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells

P. Corradini
Primo
;C. Tarella;
1999

Abstract

To describe molecular monitoring of minimal residual disease in patients with myeloma who have achieved complete remission (CR) after autologous or allogeneic transplantation of hematopoietic cells.
Neoplasm, Residual; Humans; Genetic Markers; Gene Rearrangement; Transplantation, Homologous; Transplantation, Autologous; Sequence Analysis, DNA; Multiple Myeloma; Polymerase Chain Reaction; Adult; Hematopoietic Stem Cell Transplantation; Antineoplastic Combined Chemotherapy Protocols; Immunoglobulin Variable Region; Middle Aged; Tumor Markers, Biological; Female; Male; Remission Induction
Settore MED/15 - Malattie del Sangue
gen-1999
Article (author)
01 - Articolo su periodico
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/181107
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 221
  • ???jsp.display-item.citation.isi??? ND
social impact